Skip to main content
PolicySpeak
← All files
IG

innoVance GmbH

Company · Germany

2
positions filed
in the 326 files tracked
1
legislative file
of 326 tracked
0
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Track innoVance in PolicySpeak: request access →

Work at innoVance GmbH? so we know who speaks for it.

Follow the file innoVance GmbH engages with

One email on Tuesdays when a new position is filed on this file, from innoVance GmbH or from anyone else on it. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

innoVance GmbH filed 2 positions between 27 Apr 2026 and 5 May 2026, across 1 of the 326 legislative files tracked here.

What they argued

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 5 May 2026source

As a service provider for innovation-supporting measures under the Medical Technology Programme of the German Federal Ministry of Research, Technology & Space (BMFTR), we highly welcome the COM proposal to reform MDR and IVDR. Generating clinical evidence through clinical investigations for medical devices is key, but costly.

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 27 Apr 2026source

Art. 82 MDR Handling of other clinical investigations As a service provider for innovation-supporting measures under the Medical Technology Programme of the German Federal Ministry of Research, Technology and Space (BMFTR), we welcome the COM proposal to reform the MDR and IVDR. The Commission proposes the complete removal of Article 82 MDR on other clinical investigations.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Is this your organization?

Everything on this page comes from innoVance GmbH’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.